A randomized, double-blind, placebo-controlled, multicenter clinical trial investigating the efficacy and safety of Dermasectan® vs. placebo administered to adult patients with atopic dermatitis (AD)
A prospective, multicenter, comparative study of Dermasectan versus standard of care (e.g. hydrocortisone) in the current clinical practice using subjective assessment in children with atopic dermatitis
A double blind-cross-over, parallel, randomized, multicenter study to evaluate the safety and efficacy of LTS035 (Lactosectan) vs placebo in adult subjects with intolerance to certain foods, primarily lactose intolerant
100 Clinical Results associated with Novintethical Pharma SA
0 Patents (Medical) associated with Novintethical Pharma SA
100 Deals associated with Novintethical Pharma SA
100 Translational Medicine associated with Novintethical Pharma SA